Actinomyces species: A Danish Survey on Human Infections and Microbiological Characteristics

Department of Bacteriology, Mycology and Parasitology, Statens Serum Institute, Copenhagen, Departments of Clinical Microbiology.
The Open Microbiology Journal 02/2009; 3(1):113-20. DOI: 10.2174/1874285800903010113
Source: PubMed

ABSTRACT This study compared phenotypic and genotypic identification of Actinomyces strains, tested susceptibility to antibiotics and evaluated their clinical importance. Thirty-four Actinomyces strains were examined; sixteen type strains, and 18 clinical strains from different hospitals in Denmark from the period 2003-2005. Partial 16S rDNA sequencing using a stretch of 526 bases was used for genotypic identification. Susceptibility testing was done by E-test. The antibiotics examined were: benzylpenicillin, piperacillin with tazobactam, ceftriaxone, meropenem, erythromycin, clindamycin, linezolid, moxifloxacin, tetracycline and tigecycline. Clinical parameters were obtained by reviewing patient records. There was poor agreement between the phenotypic and genotypic identification. Phenotypic tests were helpful in identifying strains closely related by DNA sequences. The strains were sensitive to the examined antibiotics except for moxifloxacin to which most strains were resistant, and a few strains were resistant to meropenem and tetracycline. The clinical strains were from many different types of infections and locations. None of the patients was described as having typical actinomycetic lesions, and an apparently good outcome was obtained with different treatment regimens.

Download full-text


Available from: Jens Jørgen Christensen, Jan 15, 2014
  • Source
    • "One case of cystitis was reported in a revision of Actinomyces spp. infections in Denmark that was treated with a short-course of antimicrobials (cefuroxime and meropenem for 9 days) [6]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bacteremia due to Actinomyces neuii has been reported in the literature 14 times. A. neuii is an endogenous organism that has been cultured in clinical specimens of the genitourinary tract; we are reporting a unique case of Actinomyces neuii postoperative testicular abscess with bacteremia which was successfully treated with surgery and a short course of parenteral antimicrobials.
    01/2014; 1(3). DOI:10.1016/j.idcr.2014.05.002
  • Source
    • "Pulmonary actinomycosis is a rare bacterial infection that is sometimes difficult to diagnose. Currently, PCR following 16S rRNA gene sequencing is the preferred method of detecting Actinomyces in clinical material (Hansen et al., 2009). This disease generally results in non-specific respiratory symptoms and various radiological findings. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We report what is believed to be the first case of pulmonary Actinomyces graevenitzii infection presenting as organizing pneumonia. Fever and night sweats developed in a 69-year-old male. The only abnormal laboratory data were an elevated erythrocyte sedimentation rate and C-reactive protein level. On chest images, multiple consolidations with air bronchograms were seen in the bilateral lungs. Histological examination from lung biopsy revealed a pattern of organizing pneumonia with microabscesses, but definitive diagnosis was not obtained because culture from lung specimen was negative. A. graevenitzii was eventually identified in the lung biopsy specimen by detection of an Actinomyces-specific PCR product followed by 16S rRNA gene sequencing. The patient was treated with high-dose ampicillin intravenously for 1 month, followed by oral amoxicillin and clarithromycin for 6 months, and recovered. We suggest that actinomycosis can present as organizing pneumonia, and identification of infection by PCR analysis and rRNA gene sequencing is a useful strategy in cases that are difficult to diagnose.
    Journal of Medical Microbiology 04/2012; 61(Pt 8):1156-8. DOI:10.1099/jmm.0.040394-0 · 2.27 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Anaerobic bacteria are the predominant indigenous flora of humans and, as a result, play an important role in infections, some of which are serious with a high mortality rate. These opportunistic pathogens are frequently missed in cultures of clinical samples because of shortcomings in collection and transport procedures as well as lack of isolation and susceptibility testing of anaerobes in many clinical microbiology laboratories. Correlation of clinical failures with known antibacterial resistance of anaerobic bacteria is seldom possible. Changes in resistance over time, and the discovery and characterization of resistance determinants in anaerobic bacteria, has increased recognition of problems in empirical treatment and has even resulted in changes in treatment guidelines. This review discusses the role of anaerobic bacteria in the normal flora of humans, their involvement in different mixed infections, developments in antibacterial resistance of the most frequent anaerobic pathogens and possible new treatment options.
    Drugs 05/2010; 70(7):841-58. DOI:10.2165/11534490-000000000-00000 · 4.13 Impact Factor
Show more